Design of antimicrobial stewardship care bundles on the high dependency unit

Alison Coll, Moira Kinnear, Anne Kinnear

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background Antimicrobial guidelines aim to optimise treatment and minimise development of resistance. Care bundles support the implementation of local guidelines. Objective Pharmacist identification of where in the prescribing, monitoring and documentation process, the quality of antimicrobial management in a High Dependency Unit of a large teaching hospital could be improved and design of antimicrobial care bundles for initiation and de-escalation of therapy to standardise care and improve practice. Setting This study was conducted in a 10-bed, mixed medical-surgical HDU in a large Scottish (UK) teaching hospital. Methods Quality indicators (n = 30) were agreed through multidisciplinary team review with reference to the evidence base, national strategy and local policy. Adherence to these quality indicators was measured before and after the pharmacist’s contributions. Areas of non-adherence to quality indicators were used to design the care bundles. Main outcome measure Adherence to the quality indicators before and after the pharmacist’s action. Categorisation of pharmaceutical care issues (‘check’, ‘change in drug therapy’ and ‘change in drug therapy process’) were quantified. Results From 134 prescriptions, the pharmacist undertook 1,447 actions to ensure adherence to the 30 indicators. Adherence was very good (85.3 % CI 83.5, 87.1), but would have been unsatisfactory (53.5 % CI 50.9, 56.1) without the pharmacist’s action (p < 0.001). Change in drug therapy process or change in drug therapy initiated by the pharmacist accounted for 31.9 % (CI 29.5, 34.3) of adherence. Non-adherence was related to documentation of past allergic reactions, bacteriological specimen results, indication and length of course of treatment (both at initiation and de-escalation). Care bundles were designed to target areas of non-adherence to local guidelines. Conclusion The pharmacist made a significant contribution to improving adherence to evidence based antimicrobial prescribing quality indicators agreed by the multidisciplinary team. Prompts have been identified from the pharmaceutical care process and applied in the design of two antimicrobial care bundles proposed to support adherence with antimicrobial prescribing policies and guidelines.
LanguageEnglish
Pages845-854
Number of pages10
JournalInternational Journal of Clinical Pharmacy
Volume34
Issue number6
DOIs
Publication statusPublished - 2012

Fingerprint

Patient Care Bundles
Drug therapy
Pharmacists
Teaching
Guidelines
Drug Therapy
Pharmaceutical Services
Teaching Hospitals
Documentation
Pharmaceutical Preparations
Monitoring
Prescriptions
Hypersensitivity
Therapeutics
Outcome Assessment (Health Care)

Keywords

  • antimicrobial stewardship
  • care bundle
  • pharmacist
  • prescribing indicator
  • quality assurance
  • Scotland
  • United Kingdom

Cite this

Coll, Alison ; Kinnear, Moira ; Kinnear, Anne. / Design of antimicrobial stewardship care bundles on the high dependency unit. In: International Journal of Clinical Pharmacy. 2012 ; Vol. 34, No. 6. pp. 845-854.
@article{ae02c13c91854326a8e2660f06f893c2,
title = "Design of antimicrobial stewardship care bundles on the high dependency unit",
abstract = "Background Antimicrobial guidelines aim to optimise treatment and minimise development of resistance. Care bundles support the implementation of local guidelines. Objective Pharmacist identification of where in the prescribing, monitoring and documentation process, the quality of antimicrobial management in a High Dependency Unit of a large teaching hospital could be improved and design of antimicrobial care bundles for initiation and de-escalation of therapy to standardise care and improve practice. Setting This study was conducted in a 10-bed, mixed medical-surgical HDU in a large Scottish (UK) teaching hospital. Methods Quality indicators (n = 30) were agreed through multidisciplinary team review with reference to the evidence base, national strategy and local policy. Adherence to these quality indicators was measured before and after the pharmacist’s contributions. Areas of non-adherence to quality indicators were used to design the care bundles. Main outcome measure Adherence to the quality indicators before and after the pharmacist’s action. Categorisation of pharmaceutical care issues (‘check’, ‘change in drug therapy’ and ‘change in drug therapy process’) were quantified. Results From 134 prescriptions, the pharmacist undertook 1,447 actions to ensure adherence to the 30 indicators. Adherence was very good (85.3 {\%} CI 83.5, 87.1), but would have been unsatisfactory (53.5 {\%} CI 50.9, 56.1) without the pharmacist’s action (p < 0.001). Change in drug therapy process or change in drug therapy initiated by the pharmacist accounted for 31.9 {\%} (CI 29.5, 34.3) of adherence. Non-adherence was related to documentation of past allergic reactions, bacteriological specimen results, indication and length of course of treatment (both at initiation and de-escalation). Care bundles were designed to target areas of non-adherence to local guidelines. Conclusion The pharmacist made a significant contribution to improving adherence to evidence based antimicrobial prescribing quality indicators agreed by the multidisciplinary team. Prompts have been identified from the pharmaceutical care process and applied in the design of two antimicrobial care bundles proposed to support adherence with antimicrobial prescribing policies and guidelines.",
keywords = "antimicrobial stewardship, care bundle, pharmacist, prescribing indicator, quality assurance, Scotland, United Kingdom",
author = "Alison Coll and Moira Kinnear and Anne Kinnear",
year = "2012",
doi = "10.1007/s11096-012-9680-9",
language = "English",
volume = "34",
pages = "845--854",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7711",
number = "6",

}

Design of antimicrobial stewardship care bundles on the high dependency unit. / Coll, Alison; Kinnear, Moira; Kinnear, Anne.

In: International Journal of Clinical Pharmacy, Vol. 34, No. 6, 2012, p. 845-854.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Design of antimicrobial stewardship care bundles on the high dependency unit

AU - Coll, Alison

AU - Kinnear, Moira

AU - Kinnear, Anne

PY - 2012

Y1 - 2012

N2 - Background Antimicrobial guidelines aim to optimise treatment and minimise development of resistance. Care bundles support the implementation of local guidelines. Objective Pharmacist identification of where in the prescribing, monitoring and documentation process, the quality of antimicrobial management in a High Dependency Unit of a large teaching hospital could be improved and design of antimicrobial care bundles for initiation and de-escalation of therapy to standardise care and improve practice. Setting This study was conducted in a 10-bed, mixed medical-surgical HDU in a large Scottish (UK) teaching hospital. Methods Quality indicators (n = 30) were agreed through multidisciplinary team review with reference to the evidence base, national strategy and local policy. Adherence to these quality indicators was measured before and after the pharmacist’s contributions. Areas of non-adherence to quality indicators were used to design the care bundles. Main outcome measure Adherence to the quality indicators before and after the pharmacist’s action. Categorisation of pharmaceutical care issues (‘check’, ‘change in drug therapy’ and ‘change in drug therapy process’) were quantified. Results From 134 prescriptions, the pharmacist undertook 1,447 actions to ensure adherence to the 30 indicators. Adherence was very good (85.3 % CI 83.5, 87.1), but would have been unsatisfactory (53.5 % CI 50.9, 56.1) without the pharmacist’s action (p < 0.001). Change in drug therapy process or change in drug therapy initiated by the pharmacist accounted for 31.9 % (CI 29.5, 34.3) of adherence. Non-adherence was related to documentation of past allergic reactions, bacteriological specimen results, indication and length of course of treatment (both at initiation and de-escalation). Care bundles were designed to target areas of non-adherence to local guidelines. Conclusion The pharmacist made a significant contribution to improving adherence to evidence based antimicrobial prescribing quality indicators agreed by the multidisciplinary team. Prompts have been identified from the pharmaceutical care process and applied in the design of two antimicrobial care bundles proposed to support adherence with antimicrobial prescribing policies and guidelines.

AB - Background Antimicrobial guidelines aim to optimise treatment and minimise development of resistance. Care bundles support the implementation of local guidelines. Objective Pharmacist identification of where in the prescribing, monitoring and documentation process, the quality of antimicrobial management in a High Dependency Unit of a large teaching hospital could be improved and design of antimicrobial care bundles for initiation and de-escalation of therapy to standardise care and improve practice. Setting This study was conducted in a 10-bed, mixed medical-surgical HDU in a large Scottish (UK) teaching hospital. Methods Quality indicators (n = 30) were agreed through multidisciplinary team review with reference to the evidence base, national strategy and local policy. Adherence to these quality indicators was measured before and after the pharmacist’s contributions. Areas of non-adherence to quality indicators were used to design the care bundles. Main outcome measure Adherence to the quality indicators before and after the pharmacist’s action. Categorisation of pharmaceutical care issues (‘check’, ‘change in drug therapy’ and ‘change in drug therapy process’) were quantified. Results From 134 prescriptions, the pharmacist undertook 1,447 actions to ensure adherence to the 30 indicators. Adherence was very good (85.3 % CI 83.5, 87.1), but would have been unsatisfactory (53.5 % CI 50.9, 56.1) without the pharmacist’s action (p < 0.001). Change in drug therapy process or change in drug therapy initiated by the pharmacist accounted for 31.9 % (CI 29.5, 34.3) of adherence. Non-adherence was related to documentation of past allergic reactions, bacteriological specimen results, indication and length of course of treatment (both at initiation and de-escalation). Care bundles were designed to target areas of non-adherence to local guidelines. Conclusion The pharmacist made a significant contribution to improving adherence to evidence based antimicrobial prescribing quality indicators agreed by the multidisciplinary team. Prompts have been identified from the pharmaceutical care process and applied in the design of two antimicrobial care bundles proposed to support adherence with antimicrobial prescribing policies and guidelines.

KW - antimicrobial stewardship

KW - care bundle

KW - pharmacist

KW - prescribing indicator

KW - quality assurance

KW - Scotland

KW - United Kingdom

UR - http://www.scopus.com/inward/record.url?scp=84872176214&partnerID=8YFLogxK

U2 - 10.1007/s11096-012-9680-9

DO - 10.1007/s11096-012-9680-9

M3 - Article

VL - 34

SP - 845

EP - 854

JO - International Journal of Clinical Pharmacy

T2 - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7711

IS - 6

ER -